S-1

Company

Ernexa Therapeutics Inc.

Filed

April 17, 2023

Accession Number

0001140361-23-018529

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →